Načítá se...
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group
BACKGROUND: Corticosteroids are the mainstay of treatment for peritumor edema but are often associated with significant side effects. Therapies that can reduce corticosteroid use would potentially be of significant benefit to patients. However, currently there are no standardized endpoints evaluatin...
Uloženo v:
| Vydáno v: | Neuro Oncol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6007454/ https://ncbi.nlm.nih.gov/pubmed/29788429 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy056 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|